Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Liminatus Pharma, Inc.

Get SEC filing alerts via email and in your feed for Liminatus Pharma, Inc.

LIMN LIMNW

Liminatus Pharma, Inc.

Latest SEC Filings from Liminatus Pharma, Inc.

1
1
Liminatus Pharma, Inc. Liminatus Pharma Reports Increased Losses and Improved Liquidity in Latest 10-Q Filing

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
Liminatus Pharma, Inc. Liminatus Pharma Reports $10.2 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Liminatus Pharma, Inc. Liminatus Pharma Reports Improved Net Loss and Significant Business Changes in Latest 10-Q

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Liminatus Pharma, Inc. Liminatus Pharma Reports Net Income of $113,287 in Q2 2025, Significant Improvement from Prior Year

Via official filing (AI summary) | 8 months ago | 0 comments

5
1
Liminatus Pharma, Inc. Liminatus Pharma Reports Increased Net Loss and Financial Deficit Following Business Combination

Via official filing (AI summary) | about 1 year ago | 0 comments